These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 136337

  • 1. Neuroleptic induced extrapyramidal symptoms.
    Donlon PT, Stenson RL.
    Dis Nerv Syst; 1976 Nov; 37(11):629-35. PubMed ID: 136337
    [Abstract] [Full Text] [Related]

  • 2. [A new synthetic antiparkinsonian drug, tropatepine hydrochloride in extrapyramidal syndromes induced by neuroleptics].
    Lambert A, dachary JM, Marie C, Oules J, Pagot R, Sales M, Vauterin C.
    Encephale; 1976 Nov; 2(2):115-21. PubMed ID: 776591
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms.
    Murphy JE, Stewart RB.
    Am J Hosp Pharm; 1979 May; 36(5):641-4. PubMed ID: 36755
    [Abstract] [Full Text] [Related]

  • 4. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM, Cellar JS, Bowers MB, Nelson JC, Takeshita J, Zigun B.
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [Abstract] [Full Text] [Related]

  • 5. Use or abuse of antiparkinsonian drugs by psychiatric patients.
    Saran AS.
    J Clin Psychiatry; 1986 Mar; 47(3):130-2. PubMed ID: 2869028
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG.
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)].
    Bourgeois M, Bouey P.
    Ann Med Psychol (Paris); 1976 Nov; 2(4):669-708. PubMed ID: 1020864
    [No Abstract] [Full Text] [Related]

  • 11. [Extrapyramidal-motoric syndrome due to psychotropic drugs].
    Huffmann G.
    MMW Munch Med Wochenschr; 1979 Jun 01; 121(22):749-50. PubMed ID: 157430
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Movement disorders with neuroleptic drug treatment.
    Tarsy D.
    Psychiatr Clin North Am; 1984 Sep 01; 7(3):453-71. PubMed ID: 6148742
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Extra-pyramidal syndrome caused by neuroleptics].
    Lambert PA.
    Encephale; 1973 Sep 01; 62(1):78-105. PubMed ID: 4718697
    [No Abstract] [Full Text] [Related]

  • 17. [Tardive dyskinesia induced by neuroleptics. A review of the literature].
    Diepart E, Cottereau MJ, Deniker P.
    Encephale; 1979 Sep 01; 5(4):317-37. PubMed ID: 42528
    [Abstract] [Full Text] [Related]

  • 18. Possible predictors of neuroleptic-resistant schizophrenic relapse: influence of negative symptoms and acute extrapyramidal side effects.
    Kinon BJ, Kane JM, Chakos M, Munne R.
    Psychopharmacol Bull; 1993 Sep 01; 29(3):365-9. PubMed ID: 7907184
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
    Moleman P, Schmitz PJ, Ladee GA.
    J Clin Psychiatry; 1982 Dec 01; 43(12):492-6. PubMed ID: 7161250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.